Work

Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns

Year: 2021

Type: article

Study design: Observational Study

Source: Clinical Microbiology and Infection

DOI: 10.1016/j.cmi.2021.02.013

Authors: Anthony Touafchia, Haleh Bagheri, Didier Carrié, Geneviève Durrieu, Agnès Sommet, Laurent Chouchana, François Montastruc

Institutions: Centre Hospitalier Universitaire de Toulouse, Centre d’Investigation Clinique 1436, Université Paris Cité, Hôpital Cochin, Assistance Publique – Hôpitaux de Paris

Language: English

Topic: Pharmacovigilance and Adverse Drug Reactions

Subfield: Toxicology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: World Health Organization, Agence Nationale de la Recherche

Award: Early identification of risk associated with drugs used in COVID-19: analysis of global pharmacovigilance data

OpenAlex ID: W3133673950

FWCI: 16.7

Cites: 16

Cited by: 115

Related to: 10